LJ University M.Pharm Regulatory Affairs: Fees 2026, Course Duration, Dates, Eligibility

Ans. M.Pharm (Regulatory Affairs) at LJIP is unique because of its eLEVATE initiative, which provides hands-on training in e-CTD (electronic Common Technical Document) preparation - a skill directly applicable to drug dossier submissions to global regulatory agencies like US FDA, EMA, and CDSCO. The curriculum covers the full spectrum of regulatory affairs including drugs, cosmetics, food, herbal products, nutraceuticals, biologicals, and medical devices, making graduates versatile regulatory professionals. LJIP's international MoUs further provide exposure to global regulatory frameworks.

Ans. Graduates can pursue careers as Regulatory Affairs Officers/Managers, Drug Regulatory Specialists, Clinical Research Associates, Medical Writers, Pharmacovigilance Officers, and Compliance Specialists in pharmaceutical companies, CROs, regulatory consulting firms, and government bodies like CDSCO. With the global pharmaceutical industry increasingly focused on regulatory compliance and drug approvals, RA professionals are in high demand both in India and internationally. Senior roles include Regulatory Affairs Director, Head of Regulatory Affairs, and Global Regulatory Strategy Lead.

Ans. The approved intake for M.Pharm (Regulatory Affairs) at LJIP is 15 seats per year, as per the official LJ University fee structure document. The ACPC 2024 closing rank for M.Pharm Regulatory Affairs at LJIP was in the range of 3011264-3011407 (GPAT rank-based), indicating that it is among the more competitive M.Pharm specialisations at LJIP. Candidates with a strong GPAT score are advised to apply early and fill choices carefully during ACPC counselling.

Ans. Yes, the curriculum includes Good Regulatory Practice, Clinical Research Regulation, and Regulatory Aspects of Drugs and Cosmetics, which cover both Indian (CDSCO, Drugs and Cosmetics Act) and international regulatory frameworks (US FDA, EMA, ICH guidelines). LJIP's eLEVATE initiative specifically trains students in e-CTD preparation, which is the standard format for drug dossier submissions to US FDA and EMA. The institute's MoUs with US universities also provide additional exposure to international regulatory practices.

Ans. GPAT tests candidates on subjects covered in the B.Pharm curriculum, including Pharmaceutics, Pharmaceutical Chemistry, Pharmacology, Pharmacognosy, and Pharmaceutical Analysis. There is no specialisation-specific GPAT paper; the same GPAT score is used for all M.Pharm specialisations. Candidates should focus on thorough preparation of B.Pharm subjects, particularly Pharmaceutics and Pharmacology, which carry significant weightage in GPAT. GPAT coaching institutes and online resources are widely available for preparation.

Ans. Yes, M.Pharm graduates from LJIP can pursue Ph.D. in Pharmacy at LJIP itself or at other universities. LJIP offers Ph.D. programmes in Pharmacy, and the institute's SIRO recognition and strong research culture make it a good environment for doctoral research. Candidates interested in Ph.D. admission at LJIP must qualify a relevant entrance exam as per the university's Ph.D. admission process. Graduates can also apply for Ph.D. programmes at other national and international universities.